Results 31 to 40 of about 249,813 (313)
Novel findings in relation to multiple anti-atherosclerotic effects of XueZhiKang in humans
Chronic Diseases and Translational Medicine, 2018 Background: Previous studies have clearly demonstrated that XueZhiKang (XZK), an extract of cholestin, can decrease low-density lipoprotein cholesterol (LDL-C) and cardiovascular events. However, the mechanism of the effects of XZK on atherosclerosis (AS)
Rui-Xia Xu +14 more
doaj +1 more source
Frontiers in Public Health, 2023 ObjectivesThis study aimed to investigate the association between body mass index (BMI) and dyslipidemia and to explore the interaction between BMI and family history of dyslipidemia towards dyslipidemia in patients with type 2 diabetes.MethodsThis cross-
Xiang-Yu Chen +5 more
doaj +1 more source
The Effects of Obesity and Physical Activity on Dyslipidemia in Persons With Type 2 Diabetes [PDF]
The Asian Journal of Kinesiology, 2022 OBJECTIVES This study was conducted to examine the effect of obesity, and physical activity on the prevalence of dyslipidemia in persons with type 2 diabetes mellitus (T2DM). METHODS A cross-sectional, correlational design was used.
Yun-A Shin +3 more
doaj +1 more source
Kidney & Blood Pressure Research, 2023 Introduction: Immunoglobulin A nephropathy (IgAN) is one of the most common glomerulonephritic diseases in the world. Several lines of evidence have suggested that dyslipidemia is related to the disease progression and prognosis of IgAN.
Sidi Liu +5 more
doaj +1 more source
The Journal of Clinical Endocrinology & Metabolism, 2007 Recently, considerable progress has been made in understanding the genetic basis of dyslipidemias and in studying the safety and efficacy of lipid-lowering drugs for coronary heart disease (CHD) prevention. Novel loci have been identified for monogenic hypercholesterolemia, such as low-density lipoprotein (LDL) receptor (LDLR)-associated protein ...
Abhimanyu, Garg, Vinaya, Simha
openaire +2 more sources
EBioMedicine, 2018 Background: Severe hypertriglyceridemia (SHTG, TG ≥5·65 mmol/L), a disease, usually resulting from a combination of genetic and environmental factors, may increase the risk of acute pancreatitis (AP).
Jing-Lu Jin +11 more
doaj +1 more source
Cardiovascular Diabetology, 2019 Background Reverse cholesterol transport (RCT) is an important cardioprotective mechanism and the decrease in cholesterol efflux can result in the dyslipidemia.
Ya-Ru Wu +5 more
doaj +1 more source
Lipids in Health and Disease, 2023 Background and aims This study aimed to investigate the association between the Dietary Inflammatory Index (DII) and dyslipidemia, as well as to evaluate the mortality risk associated with DII in participants with dyslipidemia.
Xiaozhe Chen +8 more
doaj +1 more source
, 2011 Back ground: Dyslipidemia and residual renal function (RRF) have a significant impact on the cardiovascular mortality in dialysis patients, but their association in patients on chronic peritoneal dialysis (PD) has not been completely Studied.
CHEN, HUNG-YUAN;KAO, TZE-WAH;HUANG, JENQ-WEN;TSAI, TUN-JUN;WU, KWAN-DUN +1 more
core +1 more source
Prevalence and types of persistent dyslipidemia in patients treated with statins
, 2013 Aim To determine the prevalence and types of persistent dyslipidemia in patients treated with different statins to reduce cardiovascular disease (CVD) risk, as well as to determine the proportion of high risk patients who did not reach the lipid ...
Željko Reiner +3 more
core +1 more source